Back to search
Post-aggressive Immunosuppression
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Post-aggressive Immunosuppression trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Post-aggressive Immunosuppression trials you may qualify forThis randomized phase III trial studies how well graft-vs-host disease (GVHD) prophylaxis works in treating patients with hematologic malignancies undergoing un…
This phase II trial studies how well sirolimus, cyclosporine and mycophenolate mofetil works in preventing graft-vs-host disease (GVHD) in patients with blood c…